These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 10699325)
1. Distribution of immunoglobulin G (IgG) and A (IgA) subclasses following Q fever vaccination with soluble phase I Coxiella burnetii extract. Camacho MT; Outschoorn I; Kovácová E; Téllez A Vaccine; 2000 Mar; 18(17):1773-7. PubMed ID: 10699325 [TBL] [Abstract][Full Text] [Related]
2. Distribution of IgA subclass response to Coxiella burnetii in patients with acute and chronic Q fever. Camacho MT; Outschoorn I; Echevarría C; Kovácová E; Yebra M; Maté I; Auffray P; Téllez A Clin Immunol Immunopathol; 1998 Jul; 88(1):80-3. PubMed ID: 9683553 [TBL] [Abstract][Full Text] [Related]
3. Autoimmune component in individuals during immune response to inactivated combined vaccine against Q fever. Krutitskaya L; Tokarevich N; Zhebrun A; Kartseva N; Tarasevich I; Yablonskaya V; Fatalieva S; Misnikov OP; Vasilenko AZ Acta Virol; 1996 Sep; 40(4):173-7. PubMed ID: 9014006 [TBL] [Abstract][Full Text] [Related]
4. Increases in the levels of Coxiella burnetii-specific immunoglobulin G1 and G3 antibodies in acute Q fever and chronic Q fever. Capo C; Iorgulescu I; Mutillod M; Mege JL; Raoult D Clin Diagn Lab Immunol; 1998 Nov; 5(6):814-6. PubMed ID: 9801340 [TBL] [Abstract][Full Text] [Related]
5. Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever. Schoffelen T; Herremans T; Sprong T; Nabuurs-Franssen M; Wever PC; Joosten LA; Netea MG; van der Meer JW; Bijlmer HA; van Deuren M J Infect; 2013 Dec; 67(6):565-73. PubMed ID: 23973626 [TBL] [Abstract][Full Text] [Related]
6. Role of immunoglobulin G subclasses in Q fever. Camacho MT; Outschoorn I; Tellez A Eur J Clin Microbiol Infect Dis; 1995 Dec; 14(12):1070-5. PubMed ID: 8681982 [TBL] [Abstract][Full Text] [Related]
8. Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever. Scholzen A; Richard G; Moise L; Hartman E; Bleeker-Rovers CP; Reeves PM; Raju Paul S; Martin WD; De Groot AS; Poznansky MC; Sluder AE; Garritsen A Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331958 [TBL] [Abstract][Full Text] [Related]
9. Efficiency of various serological techniques for diagnosing Coxiella burnetii infection. Slabá K; Skultéty L; Toman R Acta Virol; 2005; 49(2):123-7. PubMed ID: 16047740 [TBL] [Abstract][Full Text] [Related]
10. Persistent high antibody titres against Coxiella burnetii after acute Q fever not explained by continued exposure to the source of infection: a case-control study. Jajou R; Wielders CC; Leclercq M; van Leuken J; Shamelian S; Renders N; van der Hoek W; Schneeberger P BMC Infect Dis; 2014 Nov; 14():629. PubMed ID: 25421141 [TBL] [Abstract][Full Text] [Related]
11. [Q fever with endocarditis: clinical presentation and serologic follow-up of 21 patients]. Duroux-Vouilloz C; Praz G; Francioli P; Péter O Schweiz Med Wochenschr; 1998 Apr; 128(14):521-7. PubMed ID: 9592893 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Q fever using indirect microimmunofluorescence. Imbert G; La Scola B Methods Mol Biol; 2006; 345():197-202. PubMed ID: 16957357 [TBL] [Abstract][Full Text] [Related]
13. Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation. Feng J; Hu X; Fu M; Dai L; Yu Y; Luo W; Zhao Z; Lu Z; Du Z; Zhou D; Wen B; Jiao J; Xiong X Vaccine; 2019 Sep; 37(41):6076-6084. PubMed ID: 31477436 [TBL] [Abstract][Full Text] [Related]
14. Components of protective immunity. Zhang G; Zhang Y; Samuel JE Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628 [TBL] [Abstract][Full Text] [Related]
15. Predominant immunoglobulin A response to phase II antigen of Coxiella burnetii in acute Q fever. Fournier PE; Raoult D Clin Diagn Lab Immunol; 1999 Mar; 6(2):173-7. PubMed ID: 10066649 [TBL] [Abstract][Full Text] [Related]
16. Control of Coxiella burnetii shedding in a dairy goat herd by annual offspring vaccination. Bauer BU; Herms TL; Jahnke R; Ossowski N; Walter MC; Frangoulidis D; Runge M; Ganter M; Knittler MR Vaccine; 2024 Nov; 42(25):126125. PubMed ID: 39025699 [TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera. Qadri F; Ahmed F; Karim MM; Wenneras C; Begum YA; Abdus Salam M; Albert MJ; McGhee JR Clin Diagn Lab Immunol; 1999 Nov; 6(6):812-8. PubMed ID: 10548569 [TBL] [Abstract][Full Text] [Related]
18. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii. Shannon JG; Heinzen RA Immunol Res; 2009; 43(1-3):138-48. PubMed ID: 18813881 [TBL] [Abstract][Full Text] [Related]
19. Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry. Deringer JR; Chen C; Samuel JE; Brown WC Microbiology (Reading); 2011 Feb; 157(Pt 2):526-542. PubMed ID: 21030434 [TBL] [Abstract][Full Text] [Related]
20. Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice. Gong W; Wang P; Xiong X; Jiao J; Yang X; Wen B PLoS One; 2015; 10(4):e0124664. PubMed ID: 25909586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]